Emergent BioSolutions (EBS) Times Interest Earned (2011 - 2026)
Emergent BioSolutions (EBS) recorded quarterly Times Interest Earned of $0.95 in Q1 2026, up 150.29% quarter-over-quarter from -$1.9 in Q4 2025, and down 71.88% on a YoY basis from $3.39 in Q1 2025.
Emergent BioSolutions (EBS) Times Interest Earned (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Times Interest Earned history runs 16 years deep, the most recent figure standing at $0.95 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 71.88% year-over-year to $0.95; the TTM figure through Mar 2026 stood at $1.09 (up 167.98% YoY), while the FY2025 annual figure was $1.69, up 210.26% from the prior year.
- Times Interest Earned was $0.95 for Q1 2026 at Emergent BioSolutions, up from -$1.9 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $7.77 in Q3 2024 to a low of -$12.29 in Q3 2023.
- Historically, Times Interest Earned has averaged -$2.57 across 5 years, with a median of -$1.9 in 2025.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned slumped 1284.87% in 2022, then soared 163.23% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$4.32 in 2022, then jumped by 53.28% to -$2.02 in 2023, then soared by 68.2% to -$0.64 in 2024, then tumbled by 195.68% to -$1.9 in 2025, then soared by 150.29% to $0.95 in 2026.
- The last three Times Interest Earned figures came in at $0.95 (Q1 2026), -$1.9 (Q4 2025), and $5.03 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn | 0.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.95 |
| Dec 31, 2025 | -1.90 |
| Sep 30, 2025 | 5.03 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 3.39 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | 7.77 |
| Jun 30, 2024 | -8.62 |
| Mar 31, 2024 | 1.64 |
| Dec 31, 2023 | -2.02 |
| Sep 30, 2023 | -12.29 |
| Jun 30, 2023 | -10.24 |
| Mar 31, 2023 | -8.25 |
| Dec 31, 2022 | -4.32 |
| Sep 30, 2022 | -5.33 |
| Jun 30, 2022 | -9.78 |
| Mar 31, 2022 | 0.84 |
| Dec 31, 2021 | 31.87 |
| Sep 30, 2021 | -5.32 |
| Jun 30, 2021 | 0.83 |